Stock ASTRAZEN ASTRAZENECA PHARMA INDIA LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

All News AstraZeneca Pharma India Limited

Equities

ASTRAZEN

INE203A01020

Market Closed - Bombay S.E.
Other stock markets
 06:00:49 2024-04-18 am EDT 		5-day change 1st Jan Change
5,205 INR -1.59% Intraday chart for AstraZeneca Pharma India Limited -1.95% -5.71%
Apr. 08 AstraZeneca Pharma India Limited Approves Appointment of Bhavana Agrawal as Director and Whole Time Director CI
Mar. 25 AstraZeneca Pharma India Limited Appoints Vinay Sharma as Business Unit Head - Rare Disease, Effective July 1, 2024 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
AstraZeneca Pharma India Limited Approves Appointment of Bhavana Agrawal as Director and Whole Time Director
CI
AstraZeneca Pharma India Limited Appoints Vinay Sharma as Business Unit Head - Rare Disease, Effective July 1, 2024
CI
AstraZeneca, Mankind Pharma Tie Up for Exclusive Distribution of Asthma Drug Symbicort in India
MT
Astrazeneca Pharma India Ltd and Mankind Pharma Partner to Accelerate Access to Asthma Medicine for Patients in India
CI
Astrazeneca Pharma India Limited Announces Board Changes
CI
AstraZeneca Pharma India Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
CI
AstraZeneca Pharma India Limited Announces Board Changes
CI
AstraZeneca Pharma India Limited Announces Directorate Appointments
CI
AstraZeneca Gets Indian Drug Regulator's Nod to Import Andexanet Alfa Powder for Solution for Infusion
MT
Astrazeneca Pharma to Launch Breast Cancer Treatment Drug in India in January 2024
MT
India's Nifty set for muted open after steep drop
RE
Astrazeneca Pharma India Limited Appoints Hooi-Bien Chuah as Additional Director (Non-Executive)
CI
AstraZeneca Pharma India Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
CI
AstraZeneca Gets Indian Drug Regulator's Nod to Import Pharmaceutical Formulations for Palivizumab
MT
Astrazeneca Pharma India Limited Receives Permission to Import Pharmaceutical Formulations Of New Drug For Sale Or For Distribution In Form CT-20 From Central Drugs Standard Control Organisation For Palivizumab
CI
AstraZeneca Pharma India Limited Announces Management Changes
CI
Astrazeneca Pharma India Limited Announces Retirement of Rajesh Marwaha as Whole-Time Director
CI
AstraZeneca Pharma India Limited Appoints Praveen Akkinepally as the Business Unit Head ­ Oncology with Effect from November 1, 2023
CI
AstraZeneca Pharma India Limited Approves Dividend for the Financial Year 2022-2023
CI
AstraZeneca Pharma India Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ASTRAZEN Stock
  4. News AstraZeneca Pharma India Limited